chevron_leftBack
As of 6 June 2026, Thyrocare Technologies Ltd. has a market cap of $665.83M USD, ranking #13250 globally and #718 in India.
It ranks #1205 in the Healthcare sector, and #142 in the Medical Care Facilities industry.
Key Stats
Market Cap
$665.83MUSD
63.75B INR
Enterprise Value
$650.8MUSD
62.08B INR
Revenue (TTM)
$82.74MUSD
7.92B INR
EBITDA (TTM)
$25.02MUSD
2.39B INR
Net Income (TTM)
$14.36MUSD
1.37B INR
EBITDA Margin
30%
Profit Margin
17%
PE Ratio
46.4
Forward PE
34.9
PS Ratio
8.0
PB Ratio
11.9
EV/EBITDA
25.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Rahul Guha
open_in_new
Employees
1,822
Founded
1996
Website
thyrocare.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1% | 4.3% | 12% | -12% | -8.8% | 33% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
THYROCARE
Thyrocare Technologies Ltd
ISIN: INE594H01019
Shares Out.:
Shares Outstanding:
159.165M1
Shares Float:
62.028M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
400.30 INR | |
|
539871
(THYROCARE)
Thyrocare Technologies Ltd
ISIN: INE594H01019
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
404.05 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Thyrocare Technologies Ltd.
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: APOLLOHOSP
|
$11.47B
2K%
1.1T INR
|
60.9
|
|
NSE: MAXHEALTH
|
$10.22B
1K%
978.68B INR
|
69.0
|
|
NSE: FORTIS
|
$7.37B
1K%
706.04B INR
|
73.6
|
|
NSE: NH
|
$3.76B
464%
359.57B INR
|
46.2
|
|
NSE: MEDANTA
|
$3.14B
371%
300.37B INR
|
58.5
|
|
|
$2.78B
318%
266.19B INR
|
88.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
ADX: IHC
|
$232.18B
35K%
852.82B AED
|
44.1
|
|
NYSE: HCA
|
$96.73B
14K%
|
14.9
|
|
XETRA: FRE
|
$26.68B
4K%
22.97B EUR
|
15.0
|
|
AMS: PHIA
|
$25.58B
4K%
22.02B EUR
|
24.9
|
|
TADAWUL: 4013
|
$22.48B
3K%
84.42B SAR
|
35.2
|
|
NYSE: LH
|
$21.13B
3K%
|
24.6
|
chevron_leftBack